Lisata Therapeutics Inc.

Doing business as Caladrius Biosciences

UEI
USWTE8MPR7H1
CAGE
4LJL0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
lisata.com
Founded
2006
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Development of novel therapeutic agents that target cancer stem cells HHSN261201500046C National Cancer Institute (NIH) $150,000

Grant awards

Award Agency Obligated Awarded
Exploratory clinical study to evaluate the potential bioactivity of CLBS14 in patients with coronary microvascular… R44HL135889 National Heart Lung and Blood Institute (NIH) $1,723,324
Development of adult pluripotent very small embryonic like (vsel) stem cells to t R43AR062432 National Institutes of Health $147,765
Repair of bone defects with human autologous pluripotent very small embryonic LIK R44DE022493 National Institutes of Health $411,775
Development of human, autologous, pluripotent very small embryonic like (vsels) s R43AI098325 National Institutes of Health $595,252
Development of autologous pluripotent very small embryonic-like stem cells (vsels) to treat osteoporosis W81XWH1110684 Department of Defense $1,639,544

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Lisata Therapeutics Inc. registered in SAM.gov?

Lisata Therapeutics Inc.'s SAM.gov registration expired on July 11, 2025.

What is Lisata Therapeutics Inc.'s most recent federal award?

Lisata Therapeutics Inc.'s most recent federal grant award is Exploratory clinical study to evaluate the potential bioactivity of CLBS14 in patients with coronary microvascular… (R44HL135889), from National Heart Lung and Blood Institute (NIH), on September 20, 2017.

On GovTribe

See Lisata Therapeutics Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login